Dirui Industrial Co

Dirui Industrial Co EBIT per Share

The EBIT per Share of Dirui Industrial Co (300396.SZ) as of Oct 21, 2026 is -0.32 CNY. In the previous year, EBIT per Share was 0.52 CNY — a change of -161.09% (lower).

EBIT per Share

-0.32CNY

YoY

-161.09%

Last updated:

EBIT per Share of Dirui Industrial Co is 2025 -0.32 CNY. EBIT per Share of Dirui Industrial Co was 2024 0.52 CNY. It decreases by -161.09% lower compared to the previous year.

The Dirui Industrial Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
1.11 CNY
Jan 1, 2021
0.83 CNY
Jan 1, 2022
1.03 CNY
Jan 1, 2023
1.08 CNY
Jan 1, 2024
0.52 CNY
Jan 1, 2025
-0.32 CNY
Jan 1, 2026 (e)
0.28 CNY
Jan 1, 2027 (e)
0.37 CNY
The Dirui Industrial Co EBIT per Share history
YEAREBIT per ShareYoY
est0.37CNY+36.07%
est0.28CNY-185.88%
-0.32CNY-161.09%
0.52CNY-51.48%
1.08CNY+5.53%
1.03CNY+23.87%
0.83CNY-25.40%
1.11CNY+0.31%
1.11CNY+13.24%
0.98CNY+12.32%
0.87CNY+46.97%
0.59CNY+40.29%
0.42CNY+24.84%
0.34CNY-23.12%
0.44CNY+41.82%
0.31CNY+6.70%
0.29CNY+30.22%
0.22CNY+230.79%
0.07CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dirui Industrial Co Stock analysis

What does Dirui Industrial Co do? Dirui Industrial Co., Ltd. generates revenue through the research, development, production, and sale of medical testing instruments and supporting test paper reagents. The company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series, and blood cell analysis series, which are used for routine physical examinations and diagnosis of illness. Domestic and overseas markets are the primary distribution channels for these products, with the firm targeting healthcare providers and diagnostic laboratories that require reliable testing solutions for patient care. The company's product portfolio focuses on diagnostic tools essential for clinical settings, serving both domestic and international healthcare sectors. By offering a comprehensive range of testing instruments and reagents, Dirui Industrial addresses the needs of medical facilities seeking efficient and accurate diagnostic capabilities. The firm's products are integral to routine health screenings and medical diagnostics, supporting healthcare professionals in patient assessment and treatment planning. Dirui Industrial's business model relies on direct sales to healthcare institutions and distributors operating within domestic and overseas markets. The company's products are positioned as essential diagnostic tools for routine physical examinations and illness diagnosis, appealing to a broad spectrum of medical practitioners and facilities. This approach ensures consistent demand for their instruments and reagents across various healthcare environments. Dirui Industrial Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dirui Industrial Co stock

EBIT per Share of Dirui Industrial Co is -0.32 CNY in 2025.

EBIT per Share of Dirui Industrial Co changed from 0.52 CNY to -0.32 CNY, representing a -161.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Dirui Industrial Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Dirui Industrial Co

All Key Metrics — Dirui Industrial Co